Overview
Abbott's neuromodulation division offers spinal cord stimulation, deep brain stimulation, and dorsal root ganglion therapies through products like the Proclaim DRG Neurostimulator and Infinity DBS system. Their BurstDR stimulation technology has been clinically shown to provide superior chronic pain relief compared to traditional tonic stimulation.
More in Neuromodulation
Latest industry news
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-09-23 · Policy
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Company details
Category
⚡ Neuromodulation
Location
Austin, TX, USA
Funding
NYSE: ABT
Website
abbott.com/neuromodulationListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →